Abstract: Disclosed is a gap junction inhibitor which is more practically useful compared with carbenoxolone. Also disclosed is a novel glycyrrhetinic acid derivative. The glycyrrhetinic acid derivative is represented by general formula (1) or (2).
Type:
Grant
Filed:
July 15, 2009
Date of Patent:
February 19, 2013
Assignees:
INI Corporation, University Corporation Nagoya University